Carderock Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,409	Closed	-$2.84M	–	65
2022 Q3	$2.84M	Sell	34,409 -20,227	-37%	-$1.95M	1.45%	31
2022 Q2	$5.2M	Sell	54,636 -9,780	-15%	-$1.01M	2.17%	14
2022 Q1	$7.58M	Sell	64,416 -1,404	-2%	-$158K	2.45%	9
2021 Q4	$8.53M	Buy	65,820 +21,521	+49%	+$2.51M	2.05%	20
2021 Q3	$5.01M	Buy	44,299 +1,050	+2%	+$120K	1.41%	31
2021 Q2	$4.48M	Sell	43,249 -2,633	-6%	-$248K	1.23%	39
2021 Q1	$3.84M	Buy	45,882 +50	+0.1%	+$4.23K	1.15%	44
2020 Q4	$4.18M	Buy	45,832 +562	+1%	+$46.6K	1.26%	39
2020 Q3	$3.61M	Buy	45,270 +2,179	+5%	+$170K	1.22%	39
2020 Q2	$2.98M	Buy	43,091 +26,291	+156%	+$1.87M	1.1%	43
2020 Q1	$1.06M	Sell	16,800 -135	-0.8%	-$9.74K	0.48%	49
2019 Q4	$1.32M	Buy	+16,935	New	+$1.32M	0.44%	57